Nezam El-Tayebat Fact CheckA scientific assessment of the “نظام الطيبات” nutrition system
Choose country

Mostly false Certainty of evidence: moderate provisional C-BAR-03

After sleeve gastrectomy reflux is inevitable, and patients must take acid-suppressing drugs for life.

Conclusion: Reflux after sleeve is common but not inevitable.
  1. Original statement
  2. Scientific assessment
  3. In plain language
  4. Studies on this claim
  5. Regional context
  6. What applies in my country?
  7. References

Original statement

هو التكميم اصلا بيخلي الارتجاع حتمي

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

After sleeve gastrectomy reflux is inevitable, and patients must take acid-suppressing drugs for life.

Origin

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr.D Clinics - Diaa Al Awady is live!التكميم (Open source)
Published
6 May 2025
Timestamp
0:18:44 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
Claimed mechanism

The small tube-shaped stomach cannot hold contents, so everything refluxes.

Claimed health effect

Universal reflux, lifelong PPI dependence.

Population concerned

All sleeve patients

Geographic restriction by Elawady

none found

Diverging source versions

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
الخوف حقيقه ام سراب. أضرار التكميم. بين الحقيقه والسراب (Open source)
Published
19 November 2025
Timestamp
not available (transcript has no timings)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.

Scientific assessment

Mostly false – Essential parts of the statement are not supported by the evidence or are strongly exaggerated.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

That reflux affects every sleeve patient and requires lifelong PPIs.

2. What is demonstrably correct?

Reflux is frequent; PPI use is about 3.65 times more common after sleeve (I-BAR-04); one cross-sectional study found GERD symptoms in 76% at 5+ years (A-BAR-09).

3. What is wrong or exaggerated?

'Inevitable' is an exaggeration: in SLEEVEPASS 69% had no esophagitis at 10 years; in SM-BOSS reflux worsened in 31.8% and remitted in 25%.

4. What remains unclear?

Proportion needing lifelong PPIs varies widely between studies.

5. Which studies support it?

A-BAR-09, I-BAR-04.

6. Which studies contradict it?

A-BAR-07, I-BAR-05.

7. What applies to Germany and Europe?

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

8. What is known about Egypt?

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

9. What practical conclusion is appropriate?

Reflux risk should be discussed before sleeve; it is common but not universal.

Assessment details

Rationale for certainty of evidence

RCT data show that a majority do not develop esophagitis or worsening reflux.

Source quality

RCTs and meta-analysis.

Regional transferability

Directly transferable.

Individual exceptions

A substantial minority (about one third) do develop worsened reflux.

Regional scope of the claim
general (biological/medical)
Last reviewed
25 October 2026 provisional

In plain language

Elawady said reflux is 'inevitable' after sleeve gastrectomy. Studies show reflux is common, but not universal. In randomized trials roughly one third of patients had worse reflux or inflammation of the gullet, while most did not. Some patients even had less reflux after surgery.

Studies on this claim

Studies supporting the claim (2)

  • Endoscopy 5+ years after sleeve

    Sebastianelli L et al.. Obes Surg 2019 · PMID 30666544 · DOI 10.1007/s11695-019-03704-y
    Cross-sectional studycited by the Tayebat archiveabstract only checked

    About 1 in 5 had Barrett's changes; reflux symptoms rose from 22% to 76%.

    After sleeve gastrectomy reflux is inevitable, and patients must take acid-suppressing drugs for life.

    Does the study support the specific claim? Partly · Methodological quality: low · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Prevalence

    How was the study done?

    Cross-sectional

    How many people, animals or samples were studied?

    90

    What was actually found?

    High BE and GERD

    How large was the observed effect?

    BE 18.8%

    What do the results mean in everyday life?

    Reflux is frequent after sleeve

    What are the study's limitations?

    Small, no control

    What does it say about Elawady's specific claim?

    Supports reflux claim

    Do the results apply to Germany and Europe?

    European

    What can explicitly not be concluded from this study?

    Exact risk

    Scientific details →

  • Meta-analysis: Barrett's after sleeve

    Chandan S et al.. Clin Gastroenterol Hepatol 2025 · PMID 39059544 · DOI 10.1016/j.cgh.2024.06.041
    Meta-analysisindependent cross-checkabstract only checked★ key study

    About 5.6% developed new Barrett's esophagus; reflux and acid-medication use were about 3 times more frequent after sleeve.

    After sleeve gastrectomy reflux is inevitable, and patients must take acid-suppressing drugs for life.

    Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    BE after SG

    How was the study done?

    Meta-analysis

    How many people, animals or samples were studied?

    2046

    What was actually found?

    BE 5.6%; GERD x3

    How large was the observed effect?

    RR GERD 3.32

    What do the results mean in everyday life?

    Reflux is a major downside of sleeve

    What are the study's limitations?

    Heterogeneous observational

    What does it say about Elawady's specific claim?

    Supports reflux/BE claim, not 'inevitable'

    Do the results apply to Germany and Europe?

    Applicable

    What can explicitly not be concluded from this study?

    Cancer risk

    Scientific details →

Studies contradicting or limiting the claim (2)

  • Finnish trial: sleeve vs bypass after 10 years

    Salminen P et al.. JAMA Surg 2022 · PMID 35731535 · DOI 10.1001/jamasurg.2022.2229
    Randomised controlled trialcited by the Tayebat archiveabstract only checked★ key study

    Esophagitis was found in 31% after sleeve vs 7% after bypass; Barrett's esophagus was 4% in both groups.

    After sleeve gastrectomy reflux is inevitable, and patients must take acid-suppressing drugs for life.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Compare sleeve vs bypass

    How was the study done?

    RCT with 10-year follow-up

    How many people, animals or samples were studied?

    240 patients

    What was actually found?

    More esophagitis after sleeve; Barrett's equal

    How large was the observed effect?

    31% vs 7%; BE 4% vs 4%

    What do the results mean in everyday life?

    Sleeve often causes reflux damage; bypass less so

    What are the study's limitations?

    Attrition; small

    What does it say about Elawady's specific claim?

    Supports reflux claim, not sleeve-specific Barrett's

    Do the results apply to Germany and Europe?

    Directly European

    What can explicitly not be concluded from this study?

    Cancer risk

    Scientific details →

  • Swiss trial: sleeve vs bypass

    Peterli R et al.. JAMA 2018 · PMID 29340679 · DOI 10.1001/jama.2017.20897
    Randomised controlled trialindependent cross-checkabstract only checked★ key study

    Reflux got worse in about 32% after sleeve vs 6% after bypass.

    After sleeve gastrectomy reflux is inevitable, and patients must take acid-suppressing drugs for life.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Compare procedures

    How was the study done?

    RCT

    How many people, animals or samples were studied?

    217

    What was actually found?

    More reflux after sleeve

    How large was the observed effect?

    31.8% vs 6.3%

    What do the results mean in everyday life?

    Reflux is common but not universal

    What are the study's limitations?

    Exploratory reflux outcome

    What does it say about Elawady's specific claim?

    Supports increase, refutes 'inevitable'

    Do the results apply to Germany and Europe?

    European

    What can explicitly not be concluded from this study?

    Long-term BE

    Scientific details →

Studies with mixed or unclear results (0)

No studies in this group.

Regional context

Germany / EU

Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.

Egypt

No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.

What applies in my country?

General scientific assessment

Mostly false Reflux after sleeve is common but not inevitable.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

  1. Systematic Endoscopy 5 Years After Sleeve Gastrectomy Results in a High Rate of Barrett's Esophagus: Results of a Multicenter Study.. Sebastianelli L et al.. Obes Surg 2019 · PMID 30666544 · DOI 10.1007/s11695-019-03704-y
  2. Risk of De Novo Barrett's Esophagus Post Sleeve Gastrectomy: A Systematic Review and Meta-Analysis of Studies With Long-Term Follow-Up.. Chandan S et al.. Clin Gastroenterol Hepatol 2025 · PMID 39059544 · DOI 10.1016/j.cgh.2024.06.041
  3. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.. Salminen P et al.. JAMA Surg 2022 · PMID 35731535 · DOI 10.1001/jamasurg.2022.2229
  4. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.. Peterli R et al.. JAMA 2018 · PMID 29340679 · DOI 10.1001/jama.2017.20897

← Back to overview